company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10560000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10560000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10658000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10658000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-98000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4355000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3272000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,332000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7959000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8057000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,228000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-408000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-632000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8689000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8689000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8689000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8689000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1944000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.47
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1944000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.47
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1900000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 17:11:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.47
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21269000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21269000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18535000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18535000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2734000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4481000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2534000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,212000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7227000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4493000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,243000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-140000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-369000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4862000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4862000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4862000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4862000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1972000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.47
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1972000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.47
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2000000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 16:22:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.47
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30344000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30344000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,25755000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,25755000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4589000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4975000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2357000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,673000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8005000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3416000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,520000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-454000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-955000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4371000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4371000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4371000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4371000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2088000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.09
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2088000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.09
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2100000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 17:14:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.09
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32254000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32254000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29505000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29505000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2749000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6476000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2374000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,524000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9374000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6625000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1242000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,56000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-384000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1570000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8195000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8195000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8195000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8195000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22196000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22196000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22100000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:10:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41281000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41281000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34344000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34344000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6937000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6688000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3460000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,401000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10549000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3612000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1223000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,104000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1119000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4731000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4731000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4731000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4731000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27875000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27875000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27800000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q3,2011-07-01,2011-09-30,2012-11-08 16:42:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48526000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48526000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,44032000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,44032000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4494000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7009000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4572000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,933000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12514000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8020000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1210000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,105000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1105000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9125000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9125000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9125000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9125000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20105000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.32
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20105000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.32
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20200000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.32
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38280000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38280000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32518000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32518000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5762000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7627000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4631000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,456000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12714000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6952000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1415000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,78000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1337000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8289000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8289000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8289000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8289000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27915000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27915000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27600000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 17:01:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42680000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42680000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36174000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36174000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6506000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7293000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4058000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-105000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11246000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4740000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,48000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,24000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4716000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4716000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4716000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4716000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27936000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27936000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27700000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:01:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,49429000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,49429000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,42208000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,42208000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7221000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7169000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4011000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-940000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,739000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10979000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3758000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,52000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,60000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3750000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3750000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3750000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3750000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27977000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27977000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:02:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53226000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53226000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,41608000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,41608000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11618000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8004000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4436000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-748000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-31000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11661000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-43000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,52000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-210000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,243000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-62000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-62000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27980000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27980000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,60211000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,60211000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,41753000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,41753000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18458000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8867000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4261000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,443000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-5000000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8571000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9887000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,65000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-49000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9838000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9838000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9838000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9838000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28135000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28746000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28100000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:31:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59591000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59591000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36373000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36373000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23218000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8080000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4480000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,160000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-2936000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9784000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13434000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,98000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,34000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-64000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13370000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13370000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13370000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13370000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28163000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.47
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28828000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.46
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28400000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 17:00:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.47
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,60842000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,60842000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,42255000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,42255000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18587000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9083000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6888000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-485000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15486000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3101000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,319000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,44000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-275000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2826000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2826000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2826000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2826000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28745000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29568000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:15:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,70869000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,70869000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,50485000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,50485000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20384000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10013000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4020000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-281000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13752000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6632000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,213000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-86000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-299000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6333000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1214000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5119000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5119000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5119000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31814000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32614000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32000000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 17:02:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,69194000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,69194000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46602000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46602000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22592000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10695000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10037000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1458000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19274000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3318000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,233000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,157000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-76000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3242000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,173000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3069000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3069000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3069000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31873000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32665000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30700000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 17:02:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65359000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65359000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46589000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46589000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18770000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10914000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3677000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-737000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,872000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14726000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4044000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,195000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-536000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-731000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3313000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1387000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1926000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1926000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1926000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31895000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32960000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32100000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q3,2014-07-01,2014-09-30,2015-11-03 17:02:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83561000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83561000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,59145000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,59145000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24416000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11605000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9075000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1511000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,197000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19366000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5050000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1547000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-213000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1760000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3290000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-23547000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26837000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26837000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26837000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31882000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.84
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32745000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.82
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-410600000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.41
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,82645000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,82645000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,60720000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,60720000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21925000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13125000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5315000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-885000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4559000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22114000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-189000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,330000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1056000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1386000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1575000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,319000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1894000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1894000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1894000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32043000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32043000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31600000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q1,2015-01-01,2015-03-31,2016-05-03 17:16:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,77345000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,77345000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,58904000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,58904000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18441000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11410000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5419000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-293000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,714000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17250000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1191000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,132000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,516000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,384000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1575000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1831000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-256000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-256000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-256000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32161000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32161000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25600000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:21:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,75199000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,75199000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,50837000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,50837000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24362000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11403000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7923000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-333000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1180000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2447000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22620000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1742000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,188000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1686000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1874000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-132000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1663000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1795000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1795000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1795000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32747000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32747000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35900000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q3,2015-07-01,2015-09-30,2015-11-03 17:02:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83107000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83107000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,60096000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,60096000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23011000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13993000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10488000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1058000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,45158000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1695000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,70276000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47265000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,120000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-564000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-684000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47949000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-30012000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17937000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17937000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17937000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32439000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32439000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32700000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,67795000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,67795000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,50948000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,50948000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16847000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12124000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6757000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5785000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1398000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-2000000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24064000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7217000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,131000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1094000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,963000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6254000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1266000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4988000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4988000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4988000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32829000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32829000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33300000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 17:16:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,71721000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,71721000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,54368000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,54368000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17353000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11726000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6630000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-186000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1452000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-1800000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17822000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-469000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,101000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-98000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-567000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-52000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-515000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-515000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-515000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32856000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32856000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25800000.0
Sagent Pharmaceuticals Inc,SGNT,,0001369786,2016.0,Q2,2016-04-01,2016-06-30,2016-08-05 16:21:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
